You are here
Clinical Trials: Wounds and Injuries
Each Clinical Trial will open in a new browser window or tab.
Condition: Traumatic Brain Injury
Interventions: Biological: autologous bone marrow mononuclear cells; Other: Placebo Infusion
Sponsors: The University of Texas Health Science Center, Houston; National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified April 2016
Interventions: Biological: autologous bone marrow mononuclear cells; Other: Placebo Infusion
Sponsors: The University of Texas Health Science Center, Houston; National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified April 2016
Condition: Lateral Epicondylitis
Intervention: Biological: ALLO-ASC(allogeneic adipose derived mesenchymal stem cell) injection
Sponsor: Seoul National University Hospital
Recruiting - verified November 2013
Intervention: Biological: ALLO-ASC(allogeneic adipose derived mesenchymal stem cell) injection
Sponsor: Seoul National University Hospital
Recruiting - verified November 2013
Condition: Spinal Cord Injury.
Intervention: Biological: Transplantation of Autologous stem cell [MNCs] .
Sponsor: Chaitanya Hospital, Pune
Recruiting - verified September 2014
Intervention: Biological: Transplantation of Autologous stem cell [MNCs] .
Sponsor: Chaitanya Hospital, Pune
Recruiting - verified September 2014
Condition: Spinal Cord Injury
Intervention: Biological: bone marrow derived mesenchymal stem cells
Sponsor: Guangzhou General Hospital of Guangzhou Military Command
Recruiting - verified October 2011
Intervention: Biological: bone marrow derived mesenchymal stem cells
Sponsor: Guangzhou General Hospital of Guangzhou Military Command
Recruiting - verified October 2011
Condition: Burns
Interventions: Biological: human umbilical cord mesenchymal stem cells; Biological: human cord blood mononuclear cells and human umbilical cord mesenchymal stem cells; Drug: Conventional therapy
Sponsors: Shenzhen Beike Bio-Technology Co., Ltd.; The Second Affiliated Hospital of Kunming Medical University
Recruiting - verified November 2012
Interventions: Biological: human umbilical cord mesenchymal stem cells; Biological: human cord blood mononuclear cells and human umbilical cord mesenchymal stem cells; Drug: Conventional therapy
Sponsors: Shenzhen Beike Bio-Technology Co., Ltd.; The Second Affiliated Hospital of Kunming Medical University
Recruiting - verified November 2012
Condition: Nonunion Fracture
Interventions: Biological: Mesenchymal Stem Cells; Other: Culture medium without MSC.
Sponsor: University Hospital of Liege
Not yet recruiting - verified January 2013
Interventions: Biological: Mesenchymal Stem Cells; Other: Culture medium without MSC.
Sponsor: University Hospital of Liege
Not yet recruiting - verified January 2013
Condition: Eye Injury
Interventions: Biological: conservative; Procedure: Medical Therapy
Sponsor: Ministry of Health, Malaysia
Not yet recruiting - verified May 2010
Interventions: Biological: conservative; Procedure: Medical Therapy
Sponsor: Ministry of Health, Malaysia
Not yet recruiting - verified May 2010
Conditions: Intermittent Claudication; Peripheral Vascular Diseases
Interventions: Biological: bone marrow derived mononuclear cells; Biological: placebo
Sponsor: Leiden University Medical Center
Recruiting - verified October 2007
Interventions: Biological: bone marrow derived mononuclear cells; Biological: placebo
Sponsor: Leiden University Medical Center
Recruiting - verified October 2007
Conditions: Chronic Wounds; Pressure Sores; Hematopoietic Stem Cells; Wound Healing
Intervention: Biological: Stem cell therapy
Sponsor: University Hospital, Basel, Switzerland
Recruiting - verified September 2007
Intervention: Biological: Stem cell therapy
Sponsor: University Hospital, Basel, Switzerland
Recruiting - verified September 2007
2022 AlphaMed Press ©